Dr. Amita Mahajan is a highly experienced Paediatric Oncologist based in South Delhi, with over 31 years of dedicated service in the field of pediatric oncology. She holds a distinguished academic background with qualifications including MBBS, MD, and MRCP. Dr. Mahajan is committed to providing comprehensive care and innovative treatment options for children battling cancer, ensuring that her young patients receive the best possible outcomes. As a female specialist, she brings a compassionate approach to her practice, understanding the unique emotional and medical needs of children and their families.
Fluent in both English and Hindi, Dr. Mahajan bridges communication gaps, offering support to a diverse patient population. Her expertise in pediatric oncology encompasses a range of services from diagnosis to treatment planning, using the latest advancements in medical technology and therapeutic techniques. She is recognized for her ability to work collaboratively with multidisciplinary teams to deliver personalized care.
Recognized for her contributions to the field, Dr. Mahajan remains at the forefront of research and clinical practices, continually seeking to improve the standards of care in pediatric oncology. She is dedicated not only to treating her patients but also to educating families about cancer and its management, empowering them to be active participants in their child's treatment journey. Dr. Amita Mahajan is associated with Apollo Hospitals, a leading healthcare provider known for its excellence in medical care.
- Presently Working in Apollo Hospitals since last Assignment
Memberships
Research & Publications
- Thawani R, Moghe A, Idhate T, Kalra M, Mahajan A, Anderson KE. Porphyria Cutanea Tarda in a child with Acute Lymphoblastic Leukemia. QJM 2015,Dhamija M, Mahajan A, Kalra M, Virmani A. Deferasirox in Indian children with thalassemia major: 3 years experience. Indian J Med Paediatr Oncol. 2013 Jan-Mar; 34(1): 16–20,Mittal L, Kalra M, Mahajan A. Study of Feasibility and Acceptability of Subcutaneous Implantable Ports (SIPs) in Cancer Patients. Indian J Pediatr 2012; 79(12): 1601-1604. Fauzdar A, Mahajan A, Jain D, Mishra M, Raina V. Amplification of RUNX1 gene in two cases of childhood B-cell precursor acute lymphoblastic leukemia J Clin Oncol 2009; Suppl: abstr e21000,Fauzdar A, jain D, Mishra M, Gupta N, Bhurani D, Mishra P, Mahajan A, raina V. Molecular cytogenetic study in pediatric b-lineage acute lymhoblastic leukemia: A collaborative study group from North India. J Clin Oncol 2008; Suppl: abstr e20001.Mahajan A, Faisal , Raina V. Acute Lymphoblastic leukemia: Improving outcomes in the Indian Scenario. Pediatr Blood & Cancer 2008; 48.Mahajan A, Sharma P. Pasha F. Feasibility of implantable ports in the Indian Scenario. Pediatr Blood & Cancer 2007; 49: PG.045.Mahajan A, Gupta V, Sharma P. A study of the profile of CNS tumors presenting to a new Pediatric Oncology Service in India. Pediatr Blood & Cancer 2006; 47: PJ.015.Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D,Fischer A, Friedrich W, Schulz AS: Working Party on Inborn Errors of the European Blood & Marrow Transplant Group. Severe Pulmonary Hypertension: A Frequent Complication of Stem Cell Transplantation for Malignant Infantile Osteopetrosis. Br J Haematol 2004; 124(1): 63-71.
- Booms C, Mahajan A, Jenney ME. Outcome of catheter related sepsis in pediatric oncology patients. Arch Dis Child 2002; A14:G20.Mahajan A, Jenney ME, Doull I, Westmoreland D. RSV Bronchiolitis in immunocompromised host- the role of ribavirin? Published in the Welsh Pediatric Journal, May 2002.Mahajan A, Nirmal S, English MW, Jenney ME, Lazda E. Acute Tumour lysis in Hodgkin’s disease. Med Pediatr Oncol 2002; 39(1): 69-70.Mahajan A, Foot AB, English MW, Jenney ME. Survey of immunisation practices following completion of chemotherapeutic treatment. Arch Dis Child 2001; 84 (Suppl I): A29. Chowdhry VP, Lal A, Pati HP, Arya LS. Hematological responses to hydroxyurea therapy in multitransfused thalassemic children. Indian J Pediatrics 1997: 64(3): 395-8.Lal A, Pati HP, Arya LS, Chowdhry VP. Effect of Myleran Therapy in Multitransfused Beta-Thalassemic Children. Indian Paediatrics 1995; 32(2): 238-41.

Doctor Location
FAQs
Ask your query
Have a question? Ask your query below.
Best Hospital Near me Chennai